Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chu

Showing results (21-30 of 211) with videos related to

Pageof 22
Sort By:
Clinical Colorectal Cancer|July 25, 2008
Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 studyEdward Chu
Clinical Colorectal Cancer|February 11, 2009
Clinical colorectal cancer: "2008 - the year in review"Edward Chu
Clinical Colorectal Cancer|September 10, 2009
Colorectal cancer awareness monthEdward Chu
Clinical Colorectal Cancer|April 26, 2006
Colorectal cancer awareness monthEdward Chu
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Colorectal cancer (CRC) continues to be a major public health problem in the United States and throughout the worldEdward Chu
Clinical Colorectal Cancer|July 16, 2008
Molecular biomarker development for anti-EGFR therapy: moving beyond EGFR expressionEdward Chu
Clinical Colorectal Cancer|November 28, 2002
Lessons learned from the Saltz and Mayo Clinic regimensEdward Chu
Clinical Colorectal Cancer|May 9, 2009
Colorectal cancer awareness monthEdward Chu
Oncology (Williston Park, N.Y.)|April 8, 2014
Personalized medicine and anti-EGFR antibody therapy in the treatment of metastatic colorectal cancer: KRAS and beyondEdward Chu
Clinical Colorectal Cancer|September 4, 2003
Validation of the role of angiogenesis as a chemotherapeutic targetEdward Chu
Pageof 22

Showing results (21-30 of 211) with videos related to

Sort By:
Pageof 22
Clinical Colorectal Cancer|July 25, 2008
Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 studyEdward Chu
Clinical Colorectal Cancer|February 11, 2009
Clinical colorectal cancer: "2008 - the year in review"Edward Chu
Clinical Colorectal Cancer|September 10, 2009
Colorectal cancer awareness monthEdward Chu
Clinical Colorectal Cancer|April 26, 2006
Colorectal cancer awareness monthEdward Chu
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Colorectal cancer (CRC) continues to be a major public health problem in the United States and throughout the worldEdward Chu
Clinical Colorectal Cancer|July 16, 2008
Molecular biomarker development for anti-EGFR therapy: moving beyond EGFR expressionEdward Chu
Clinical Colorectal Cancer|November 28, 2002
Lessons learned from the Saltz and Mayo Clinic regimensEdward Chu
Clinical Colorectal Cancer|May 9, 2009
Colorectal cancer awareness monthEdward Chu
Oncology (Williston Park, N.Y.)|April 8, 2014
Personalized medicine and anti-EGFR antibody therapy in the treatment of metastatic colorectal cancer: KRAS and beyondEdward Chu
Clinical Colorectal Cancer|September 4, 2003
Validation of the role of angiogenesis as a chemotherapeutic targetEdward Chu
Pageof 22